Literature DB >> 14585802

Mechanisms underlying the inhibitory effects of tachykinin receptor antagonists on eosinophil recruitment in an allergic pleurisy model in mice.

Ana Leticia Alessandri1, Vanessa Pinho, Danielle G Souza, Maria Salete de A Castro, Andre Klein, Mauro M Teixeira.   

Abstract

The activation of tachykinin NK receptors by neuropeptides may induce the recruitment of eosinophils in vivo. The aim of the present study was to investigate the effects and underlying mechanism(s) of the action of tachykinin receptor antagonists on eosinophil recruitment in a model of allergic pleurisy in mice. Pretreatment of immunized mice with capsaicin partially prevented the recruitment of eosinophils after antigen challenge, suggesting the potential contribution of sensory nerves for the recruitment of eosinophils Local (10-50 nmol per pleural cavity) or systemic (100-300 nmol per animal) pretreatment with the tachykinin NK1 receptor antagonist SR140333 prevented the recruitment of eosinophils induced by antigen challenge of immunized mice. Neither tachykinin NK2 nor NK3 receptor antagonists suppressed eosinophil recruitment. Pretreatment with SR140333 failed to prevent the antigen-induced increase of interleukin-5 concentrations in the pleural cavity. Similarly, SR140333 failed to affect the bone marrow eosinophilia observed at 48 h after antigen challenge of immunized mice. SR140333 induced a significant increase in the concentrations of antigen-induced eotaxin at 6 h after challenge. Antigen challenge of immunized mice induced a significant increase of Leucotriene B4 (LTB4) concentrations at 6 h after challenge. Pretreatment with SR140333 prevented the antigen-induced increase of LTB4 concentrations. Our data suggest an important role for NK1 receptor activation with consequent LTB4 release and eosinophil recruitment in a model of allergic pleurisy in the mouse. Tachykinins appear to be released mainly from peripheral endings of capsaicin-sensitive sensory neurons and may act on mast cells to facilitate antigen-driven release of LTB4.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14585802      PMCID: PMC1574105          DOI: 10.1038/sj.bjp.0705515

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  57 in total

1.  Effect of a 5-lipoxygenase inhibitor, ZM 230487, on cutaneous allergic inflammation in the guinea-pig.

Authors:  M M Teixeira; P G Hellewell
Journal:  Br J Pharmacol       Date:  1994-04       Impact factor: 8.739

2.  Leukotriene B4 mediates substance P-induced granulocyte infiltration into mouse skin. Comparison with antigen-induced granulocyte infiltration.

Authors:  I Iwamoto; S Tomoe; H Tomioka; S Yoshida
Journal:  J Immunol       Date:  1993-08-15       Impact factor: 5.422

3.  Substance P-induced histamine release in tracheally perfused guinea pig lungs.

Authors:  C M Lilly; A E Hall; I W Rodger; L Kobzik; K J Haley; J M Drazen
Journal:  J Appl Physiol (1985)       Date:  1995-04

4.  Substance P-induced inflammatory responses in guinea-pig skin: the effect of specific NK1 receptor antagonists and the role of endogenous mediators.

Authors:  D T Walsh; V B Weg; T J Williams; S Nourshargh
Journal:  Br J Pharmacol       Date:  1995-04       Impact factor: 8.739

5.  Neuropeptides induce rapid expression of endothelial cell adhesion molecules and elicit granulocytic infiltration in human skin.

Authors:  C H Smith; J N Barker; R W Morris; D M MacDonald; T H Lee
Journal:  J Immunol       Date:  1993-09-15       Impact factor: 5.422

6.  Mouse Eotaxin expression parallels eosinophil accumulation during lung allergic inflammation but it is not restricted to a Th2-type response.

Authors:  J A Ganzalo; G Q Jia; V Aguirre; D Friend; A J Coyle; N A Jenkins; G S Lin; H Katz; A Lichtman; N Copeland; M Kopf; J C Gutierrez-Ramos
Journal:  Immunity       Date:  1996-01       Impact factor: 31.745

Review 7.  Role of eosinophil-chemotactic C-C chemokines in cutaneous inflammation.

Authors:  J M Schröder; N Noso; M Sticherling; E Christophers
Journal:  J Leukoc Biol       Date:  1996-01       Impact factor: 4.962

8.  In vitro and in vivo effects of leukotriene B4 antagonism in a primate model of asthma.

Authors:  C R Turner; R Breslow; M J Conklyn; C J Andresen; D K Patterson; A Lopez-Anaya; B Owens; P Lee; J W Watson; H J Showell
Journal:  J Clin Invest       Date:  1996-01-15       Impact factor: 14.808

9.  NK1 receptors mediate leukocyte adhesion in neurogenic inflammation in the rat trachea.

Authors:  P Baluk; C Bertrand; P Geppetti; D M McDonald; J A Nadel
Journal:  Am J Physiol       Date:  1995-02

10.  Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model.

Authors:  P S Foster; S P Hogan; A J Ramsay; K I Matthaei; I G Young
Journal:  J Exp Med       Date:  1996-01-01       Impact factor: 14.307

View more
  4 in total

Review 1.  Tachykinins and their receptors: contributions to physiological control and the mechanisms of disease.

Authors:  Martin S Steinhoff; Bengt von Mentzer; Pierangelo Geppetti; Charalabos Pothoulakis; Nigel W Bunnett
Journal:  Physiol Rev       Date:  2014-01       Impact factor: 37.312

Review 2.  Crosstalk between the nociceptive and immune systems in host defence and disease.

Authors:  Stephen B McMahon; Federica La Russa; David L H Bennett
Journal:  Nat Rev Neurosci       Date:  2015-07       Impact factor: 34.870

Review 3.  Neurokinin receptors and their implications in various autoimmune diseases.

Authors:  Amrita Mishra; Girdhari Lal
Journal:  Curr Res Immunol       Date:  2021-07-01

Review 4.  Sense and Immunity: Context-Dependent Neuro-Immune Interplay.

Authors:  Simmie L Foster; Corey R Seehus; Clifford J Woolf; Sébastien Talbot
Journal:  Front Immunol       Date:  2017-11-03       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.